sur Bioz, Inc.
Strategic Partnership Between Bioz, Inc. and EpiCypher to Advance Epigenetics Research
Bioz, Inc., a pioneer in the field of AI software dedicated to scientific research, announces its partnership with EpiCypher, a key player in epigenetics and chromatin science. This partnership enables the integration of Bioz's dynamic digital widgets, such as Bioz Badges and Content Hubs, on the EpiCypher website.
Widgets display real-time citation data to support researchers in their decision-making. This data features excerpts from peer-reviewed publications, live citation counts, and objective Bioz Stars reviews, highlighting the products' successful use in prior research.
This collaboration aims to build researcher confidence by highlighting more than 300 publications from the past year using EpiCypher's cutting-edge genome mapping technologies. Dr. Karin Lachmi from Bioz and Keith Maier from EpiCypher highlight the benefits of this synergy, particularly in terms of product validation and user engagement.
R. H.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Bioz, Inc.